NCT00004918 2013-01-07
Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
National Cancer Institute (NCI)
Phase 1/2 Completed
Clinical Trials
1 trialsPhase 1/2 × Leukemia, Myeloid, Accelerated Phase × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all